IL22 and polycystic ovary syndrome: Furthermore, glycodeoxycholic acid (GDCA) treatment improves IR, ovarian dysfunction, and infertility in mice with PCOS, while prevention of TGR5 signaling in Tgr5−/− mice significantly reduced the enhanced IL-22 secretion by ILC3s [6].